CN103228285B - 用于心肺转流术的预充液 - Google Patents

用于心肺转流术的预充液 Download PDF

Info

Publication number
CN103228285B
CN103228285B CN201180056991.XA CN201180056991A CN103228285B CN 103228285 B CN103228285 B CN 103228285B CN 201180056991 A CN201180056991 A CN 201180056991A CN 103228285 B CN103228285 B CN 103228285B
Authority
CN
China
Prior art keywords
dextran
colloid
osmotic
solution
cardiopulmonary bypass
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CN201180056991.XA
Other languages
English (en)
Chinese (zh)
Other versions
CN103228285A (zh
Inventor
S·斯蒂恩
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
XVIVO Perfusion AB
Original Assignee
XVIVO Perfusion AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by XVIVO Perfusion AB filed Critical XVIVO Perfusion AB
Publication of CN103228285A publication Critical patent/CN103228285A/zh
Application granted granted Critical
Publication of CN103228285B publication Critical patent/CN103228285B/zh
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716—Glucans
    • A61K31/721—Dextrans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/191—Carboxylic acids, e.g. valproic acid having two or more hydroxy groups, e.g. gluconic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/14—Alkali metal chlorides; Alkaline earth metal chlorides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P41/00—Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Inorganic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • External Artificial Organs (AREA)
CN201180056991.XA 2010-11-30 2011-11-07 用于心肺转流术的预充液 Active CN103228285B (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB1020300.8A GB201020300D0 (en) 2010-11-30 2010-11-30 Product
GB1020300.8 2010-11-30
PCT/EP2011/069524 WO2012072374A1 (en) 2010-11-30 2011-11-07 Priming solutions for cardiopulmonary bypass

Publications (2)

Publication Number Publication Date
CN103228285A CN103228285A (zh) 2013-07-31
CN103228285B true CN103228285B (zh) 2016-06-01

Family

ID=43500877

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201180056991.XA Active CN103228285B (zh) 2010-11-30 2011-11-07 用于心肺转流术的预充液

Country Status (10)

Country Link
US (1) US8969323B2 (enExample)
EP (1) EP2646040B1 (enExample)
JP (1) JP6051164B2 (enExample)
CN (1) CN103228285B (enExample)
DK (1) DK2646040T3 (enExample)
ES (1) ES2575206T3 (enExample)
GB (1) GB201020300D0 (enExample)
PL (1) PL2646040T3 (enExample)
RU (1) RU2013127665A (enExample)
WO (1) WO2012072374A1 (enExample)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN110267534B (zh) 2017-01-17 2021-11-16 西维沃医疗科技有限公司 器官保存和/或灌注溶液
US11707600B2 (en) * 2020-11-18 2023-07-25 CardioDriven, Inc. Level set calibration and assurance for pulmonary artery pressure catheterization
CN117481629B (zh) * 2023-12-29 2024-03-26 成都水木医疗科技有限公司 一种多功能胶体渗透压仪及其测定方法和应用

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5358973A (en) * 1989-02-21 1994-10-25 Gert Lindblad Composition and method for prevention of adhesions between body tissues

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1594697A (en) 1977-04-19 1981-08-05 Pharmacia Ab Oligosaccharide compositions for parenteral use
CN1102851C (zh) 1993-06-04 2003-03-12 生物时间公司 类血浆溶液
SE505499C2 (sv) * 1995-12-15 1997-09-08 Stiftelsen Facthor Förvaringslösning för organ och vävnad eller delar därav från människor och djur innehållande kalcium och nitroglycerin, användning därav samt förfarande för förvaring därmed
US6794124B2 (en) 1995-12-15 2004-09-21 Stiftelsen Facthor Preservation solution
US5902800A (en) * 1998-03-27 1999-05-11 Glenpharma Dextran formulations and method for treatment of inflammatory joint disorders

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5358973A (en) * 1989-02-21 1994-10-25 Gert Lindblad Composition and method for prevention of adhesions between body tissues

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
Comparison of dextran 40 with albumin and Ringer’s lactate as components of perfusion prime for cardiopulmonary bypass in patients undergoing myocardial revascularization;MCGRATH L B ET AL;《PERFUSION》;19891231;p42左栏第2段，p43右栏第2段至p45左栏第1段，p47左栏第4段，表5，p46 *

Also Published As

Publication number Publication date
PL2646040T3 (pl) 2017-04-28
CN103228285A (zh) 2013-07-31
US8969323B2 (en) 2015-03-03
EP2646040A1 (en) 2013-10-09
JP2013544265A (ja) 2013-12-12
US20130316977A1 (en) 2013-11-28
ES2575206T3 (es) 2016-06-27
EP2646040B1 (en) 2016-03-23
GB201020300D0 (en) 2011-01-12
DK2646040T3 (en) 2016-06-13
JP6051164B2 (ja) 2016-12-27
WO2012072374A1 (en) 2012-06-07
RU2013127665A (ru) 2015-01-10

Similar Documents

Publication Publication Date Title
Blumberg et al. 0.9% NaCl (normal saline)–perhaps not so normal after all?
Boldt Use of albumin: an update
Boer et al. Choice of fluid type: physiological concepts and perioperative indications
Bartlett et al. Prolonged extracorporeal cardiopulmonary support in man
Whiting et al. Cardiopulmonary bypass in the pediatric population
Dirkes et al. Continuous renal replacement therapy in the adult intensive care unit: history and current trends
Vercueil et al. Physiology, pharmacology, and rationale for colloid administration for the maintenance of effective hemodynamic stability in critically ill patients
Medikonda et al. Trends and updates on cardiopulmonary bypass setup in pediatric cardiac surgery
CN103228285B (zh) 用于心肺转流术的预充液
Kasper et al. Failure of autologous fresh frozen plasma to reduce blood loss and transfusion requirements in coronary artery bypass surgery.
Tigchelaar et al. Comparison of three plasma expanders used as priming fluids in cardiopulmonary bypass patients
Hasija et al. Bivalirudin anticoagulation in neonates and infants undergoing cardiac surgery
Friedman et al. Hemodynamic effects of 6% and 10% hydroxyethyl starch solutions versus 4% albumin solution in septic patients
Morgan et al. Acid-base effects of a bicarbonate-balanced priming fluid during cardiopulmonary bypass: comparison with Plasma-Lyte 148. A randomised single-blinded study
Kollmar et al. Anesthetic challenges for posterior spine surgery in a patient with left ventricular assist device: a case report
Dickson et al. Continuous renal replacement in the critically ill
Berkowitz et al. Management of pediatric cardiopulmonary bypass
Davis et al. Use of thromboelastograph and factor VII for the treatment of postoperative bleeding in a pediatric patient on ECMO after cardiac surgery
Padalino et al. Modified ultrafiltration in pediatric heart surgery
Pietrini et al. Plasma substitutes therapy in pediatrics
Hothi et al. Pediatric hemodialysis prescription, complications, and future directions
Cohen Prime Solutions for the Circuit and Hemodilution Reduction Strategies
De Rosa et al. An overview of complications associated with continuous renal replacement therapy in critically ill patients
Mishra et al. A comparative study of Albumin versus 6% Hydroxyethyl starch used as priming solution for Cardiopulmonary Bypass in adults undergoing Coronary Artery Bypass Grafting
RU2723752C1 (ru) Способ интраоперационной стабилизации гомеостаза пациента при кардиохирургическом вмешательстве в условиях длительного искусственного кровообращения

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant